AlcoVet Healthcare Launches Two Advanced Ophthalmic Solutions for Companion Animals Across India

Ghaziabad, October 2025 — AlcoVet Healthcare Private Limited, a companion animal pharmaceutical company committed to advancing veterinary healthcare in India, today announced the commercial launch of two new ophthalmic products — Vet Tears HA and FurrMoxi LP — available to veterinarians, pet clinics, and authorised retail stockists across India.

The launch expands AlcoVet's Eye Care therapy portfolio and addresses a significant gap in the companion animal ophthalmology segment, where clinically relevant, purpose-formulated products specifically designed for dogs and cats have historically been underserved in the Indian market.

Vet Tears HA is a premium multi-component viscoelastic ophthalmic lubricant formulated with Sodium Hyaluronate (Hyaluronic Acid) combined with Adaptive Guar Technology and rapid-acting demulcents. Designed to closely mimic the natural tear film of companion animals, Vet Tears HA delivers immediate comfort, sustained lubrication, and corneal surface protection for dogs and cats suffering from dry eye conditions (Keratoconjunctivitis Sicca / KCS) and related ocular surface disorders.

The product is particularly suited for long-term dry eye management, post-surgical corneal recovery — including third eyelid (cherry eye) surgeries — and as a supportive lubricant therapy alongside prescription treatments. Its viscoelastic formulation ensures superior retention on the ocular surface compared to conventional saline-based drops.

FurrMoxi LP is a dual-action, preservative-free ophthalmic suspension combining Moxifloxacin 0.5% — a fourth-generation fluoroquinolone antibiotic — with Loteprednol Etabonate 0.5%, a site-active corticosteroid. This combination delivers simultaneous antibacterial action and anti-inflammatory relief, making it a precise therapeutic tool for managing bacterial ocular infections accompanied by inflammation in companion animals.

The preservative-free formulation is a key differentiator — eliminating the risk of preservative-induced ocular toxicity that is a documented concern with conventional multi-dose ophthalmic preparations. FurrMoxi LP is dispensed under Restricted Veterinary Prescription (RVP) and is particularly indicated for post-operative prophylaxis, acute anterior segment infections, and inflammatory conditions of the anterior eye.

Both products are now commercially available across India through authorised veterinary clinics, pet pharmacies, and AlcoVet's network of trained retail partners. Veterinarians and stockists interested in onboarding can reach out to AlcoVet Healthcare directly through the official partner portal.

AlcoVet Healthcare continues to expand its companion animal therapy portfolio across Eye Care, Ortho Care, Gastro Care, Skin Care, and Deworming — with further product launches planned across therapeutic segments in the coming months.